Studies related to Hepatic Glucose Production and Chromium

Characterization Of The Metabolic And Physiologic Response To Chromium Supplementation In Subjects With Type 2 Diabetes Mellitus

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 137
Sex Both Genders
Age Range 45-64
Body Types Obese
Notes for this study:
Supplementation of 1mg chromium (in the form of chromium picolinate) in two divided doses daily for 24 weeks in type II diabetics noted that while there was a trend to increase insulin sensitivity, this was not statistically significant and only 46% of persons were considered responders.

No other changes were noted in diet, glucose metabolism, and the response to chromium was more associated with baseline insulin resistance rather than the kinetics of chromium after ingestion.